Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Johnson & Johnson Enters Oversold Territory as J&J Sues HHS over 340B Payment Terms

November 18, 2024
Johnson & Johnson (J&J) is making headlines as it sues the U.S. Department of Health and Human Services (HHS) over payment terms for 340B hospitals. The pharmaceutical giant claims that the current payment terms are unfair and is seeking a resolution through legal action.

This legal battle comes at a time when J&J's stock has seen a decline of 6.7% since its last earnings report. Analysts are attributing this downtrend to the ongoing litigation and uncertainties surrounding the company's future financials.

In another development, J&J is facing hurdles in its plans for the 340B rebate program. The federal government has halted the implementation of the program, which is designed to provide discounts on prescription drugs to hospitals that serve low-income patients. J&J has responded by suing the federal government, highlighting the importance of the program for both patients and healthcare providers.

However, amidst these challenges, J&J is set to begin the clinical trial of its Ottava surgical robot. The FDA has given its approval for the trial, and the company is optimistic about the potential of this innovative technology. The Ottava surgical robot aims to revolutionize surgical procedures by offering precision and efficiency.

Investors and stock market enthusiasts are advised to seek professional guidance from Stocks Prognosis to make informed decisions regarding the future movement of J&J's stock. With the current oversold territory and ongoing legal battles, it is crucial to stay updated on the latest developments in the healthcare industry and the impact they may have on J&J's stock performance.
If you want to leave a comment, then you need Login or Register





Other data for JNJ

Related data

JNJJuly 14, 2025Johnson & Johnson Innovates with New Product Launches  ~1 min.

Johnson & Johnson, a leading pharmaceutical company, continues to make waves in the industry with its latest submission of sNDA for the schizophrenia drug CAPLYTA to the FDA....

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....

JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....

JNJFebruary 28, 2025Johnson & Johnson's Strong Performance Since Last Earnings Report Raises Expectations  ~1 min.

Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....

JNJFebruary 26, 2025The surgical devices I design for JJ speed healing and save lives  ~1 min.

Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....

JNJFebruary 18, 2025Johnson & Johnson reportedly wants to sell Cerenovus for 1B  ~1 min.

According to recent reports, Johnson & Johnson is considering selling its Cerenovus stroke business for 1 billion dollars....

CIFebruary 7, 2025The Cigna Group Launches Actions To Drive Positive Change for Customers and Patients  ~2 min.

The Cigna Group, a leading healthcare company, has recently announced a series of actions aimed at driving positive change for their customers and patients....

CVSJanuary 31, 2025New CVS Health app revolutionizes ecommerce and prescriptions  ~1 min.

CVS Health Corporation has launched a groundbreaking new app that aims to transform the healthcare industry....

CVSJanuary 8, 2025CVS Health announces groundbreaking CostVanta initiative  ~2 min.

CVS Health Corporation has recently launched its innovative CostVanta initiative, aiming to revolutionize the healthcare industry....

CVSFebruary 2, 2025CVS Health Corporation Introduces Innovative App for Ecommerce Prescriptions  ~2 min.

CVS Health Corporation, one of the leading healthcare companies in the United States, has recently launched a new app aimed at revolutionizing the way customers access and purchase their prescriptions....

CVSJanuary 2, 2025CVS Health Corporation: revolutionizing healthcare with innovative technology  ~2 min.

CVS Health Corporation (NYSE: CVS) is making waves in the healthcare industry through its extensive range of services and commitment to innovation....